Free for academic non-profit institutions. Other users need a Commercial license
This gene encodes a member of the erythroblast transformation-specific (ETS) family of transcriptions factors. All members of this family are key regulators of embryonic development, cell proliferation, differentiation, angiogenesis, inflammation, and apoptosis. The protein encoded by this gene is mainly expressed in the nucleus. It contains an ETS DNA-binding domain and a PNT (pointed) domain which is implicated in the self-association of chimeric oncoproteins. This protein is required for platelet adhesion to the subendothelium, inducing vascular cell remodeling. It also regulates hematopoesis, and the differentiation and maturation of megakaryocytic cells. This gene is involved in chromosomal translocations, resulting in different fusion gene products, such as TMPSSR2-ERG and NDRG1-ERG in prostate cancer, EWS-ERG in Ewing's sarcoma and FUS-ERG in acute myeloid leukemia. More than two dozens of transcript variants generated from combinatorial usage of three alternative promoters and multiple alternative splicing events have been reported, but the full-length nature of many of these variants has not been determined. [provided by RefSeq, Apr 2014]
ERG (ETS Transcription Factor ERG) is a Protein Coding gene. Diseases associated with ERG include Extraskeletal Ewing Sarcoma and Ewing Sarcoma. Among its related pathways are Transcriptional misregulation in cancer and Chromatin Regulation / Acetylation. Gene Ontology (GO) annotations related to this gene include DNA-binding transcription factor activity and obsolete signal transducer activity. An important paralog of this gene is FLI1.
GO ID | Qualified GO term | Evidence | PubMed IDs |
---|---|---|---|
GO:0000978 | RNA polymerase II proximal promoter sequence-specific DNA binding | IDA | 23093599 |
GO:0000981 | DNA-binding transcription factor activity, RNA polymerase II-specific | ISM | 19274049 |
GO:0001228 | DNA-binding transcription activator activity, RNA polymerase II-specific | IMP | 18195090 |
GO:0003677 | DNA binding | TAS | 8502479 |
GO:0003682 | chromatin binding | IEA | -- |
GO ID | Qualified GO term | Evidence | PubMed IDs |
---|---|---|---|
GO:0000790 | nuclear chromatin | ISA | -- |
GO:0005634 | nucleus | IEA,IBA | 21873635 |
GO:0005737 | cytoplasm | IEA | -- |
GO:0042025 | host cell nucleus | IEA | -- |
GO:1990904 | ribonucleoprotein complex | IDA | 17289661 |
SuperPathway | Contained pathways | ||
---|---|---|---|
1 | Chromatin Regulation / Acetylation | ||
2 | Endometrial cancer |
.32
|
|
3 | Transcriptional misregulation in cancer | ||
4 | TarBasePathway |
GO ID | Qualified GO term | Evidence | PubMed IDs |
---|---|---|---|
GO:0006355 | regulation of transcription, DNA-templated | IEA | -- |
GO:0006357 | regulation of transcription by RNA polymerase II | IBA | 21873635 |
GO:0006468 | protein phosphorylation | TAS | 8502479 |
GO:0007165 | signal transduction | TAS | 8502479 |
GO:0007275 | multicellular organism development | TAS | 8502479 |
Name | Status | Disease Links | Group | Role | Mechanism of Action | Clinical Trials |
---|---|---|---|---|---|---|
Bevacizumab | Approved, Investigational | Pharma | VEGF antagonist, Therapeutic Antibodies, Vascular endothelial growth factor (VEGF) and VEGF receptor (VEGFR) inhibitors | 2368 | ||
Hydroxocobalamin | Approved | Pharma | 437 | |||
Methylcobalamin | Approved, Investigational | Pharma | 370 | |||
Minocycline | Approved, Investigational | Pharma | 229 | |||
Cyanocobalamin | Approved | Nutra | 438 |
ExUns: | 1 | ^ | 2a | · | 2b | ^ | 3 | ^ | 4a | · | 4b | ^ | 5 | ^ | 6 | ^ | 7 | ^ | 8 | ^ | 9 | ^ | 10a | · | 10b | ^ | 11 | ^ | 12a | · | 12b | ^ | 13 | ^ | 14 | ^ | 15 | ^ | 16 | ^ | 17a | · | 17b | · | 17c |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
SP1: | - | - | - | - | - | - | |||||||||||||||||||||||||||||||||||||||
SP2: | - | - | - | - | - | ||||||||||||||||||||||||||||||||||||||||
SP3: | - | - | - | - | - | - | - | - | - | ||||||||||||||||||||||||||||||||||||
SP4: | - | - | - | - | - | ||||||||||||||||||||||||||||||||||||||||
SP5: | - | - | |||||||||||||||||||||||||||||||||||||||||||
SP6: | - | - | |||||||||||||||||||||||||||||||||||||||||||
SP7: | |||||||||||||||||||||||||||||||||||||||||||||
SP8: |
This gene was present in the common ancestor of animals.
Organism | Taxonomy | Gene | Similarity | Type | Details |
---|---|---|---|---|---|
Chimpanzee (Pan troglodytes) |
Mammalia | ERG 30 31 |
|
OneToOne | |
Platypus (Ornithorhynchus anatinus) |
Mammalia | ERG 31 |
|
OneToOne | |
Dog (Canis familiaris) |
Mammalia | ERG 30 31 |
|
OneToOne | |
Oppossum (Monodelphis domestica) |
Mammalia | ERG 31 |
|
OneToOne | |
Cow (Bos Taurus) |
Mammalia | ERG 30 31 |
|
OneToOne | |
Mouse (Mus musculus) |
Mammalia | Erg 30 17 31 |
|
OneToOne | |
Rat (Rattus norvegicus) |
Mammalia | Erg 30 |
|
||
Chicken (Gallus gallus) |
Aves | ERG 30 31 |
|
OneToOne | |
Lizard (Anolis carolinensis) |
Reptilia | ERG 31 |
|
OneToOne | |
Tropical Clawed Frog (Silurana tropicalis) |
Amphibia | erg 30 |
|
||
African clawed frog (Xenopus laevis) |
Amphibia | erg-A 30 |
|
||
Zebrafish (Danio rerio) |
Actinopterygii | erg 30 31 |
|
OneToOne | |
Fruit Fly (Drosophila melanogaster) |
Insecta | Ets65A 32 |
|
|
|
Ets21C 31 32 |
|
OneToMany | |||
Worm (Caenorhabditis elegans) |
Secernentea | C42D8.4 32 |
|
|
|
Sea Squirt (Ciona savignyi) |
Ascidiacea | -- 31 |
|
ManyToMany | |
-- 31 |
|
ManyToMany | |||
-- 31 |
|
ManyToMany | |||
Sea Vase (Ciona intestinalis) |
Ascidiacea | Cin.1256 30 |
|
Disorder | Aliases | PubMed IDs |
---|---|---|
extraskeletal ewing sarcoma |
|
|
ewing sarcoma |
|
|
myeloid leukemia |
|
|
sarcoma |
|
|
myxoid liposarcoma |
|